Medline Inc.
MDLNNasdaqCIK 2046386HealthcareFiscal year ends Dec 31
Latest reported revenue, Q2 FY2026$7.68bnRevenue, Q2 FY2026, three months to 2026-06-27$7.68bn. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Report this figureThree months to Jun 27, 2026, from the 10-Q filed Aug 5, 2026.Latest quarter: Q2 FY2026
Three months to Jun 27, 2026, against the same quarter a year earlier.
- Revenue$7.68bnRevenue, Q2 FY2026, three months to 2026-06-27$7.68bn. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Report this figure+11.6% on a year earlier - Gross margin28.8%Gross margin, Q2 FY2026, three months to 2026-06-27. gross profit / revenueGross profit: $2.21bn. XBRL concept
us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Revenue: $7.68bn. XBRL conceptus-gaap:Revenues. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Report this figure+1.2 pts on a year earlier - Operating margin5.1%Operating margin, Q2 FY2026, three months to 2026-06-27. operating income / revenueOperating income: $395.0m. XBRL concept
us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Revenue: $7.68bn. XBRL conceptus-gaap:Revenues. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Report this figure−4.2 pts on a year earlier - Net margin1.8%Net margin, Q2 FY2026, three months to 2026-06-27. net income / revenueNet income: $139.0m. XBRL concept
us-gaap:ProfitLoss. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Revenue: $7.68bn. XBRL conceptus-gaap:Revenues. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Report this figure−3.0 pts on a year earlier - Diluted EPS$0.07Diluted EPS, Q2 FY2026, three months to 2026-06-27$0.07 per share. XBRL concept
us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Report this figureNo year-earlier figure to compare - Free cash flow$604.0mFree cash flow, Q2 FY2026, three months to 2026-06-27. operating cash flow − capital expenditureOperating cash flow: $715.0m. XBRL concept
us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0002046386-26-000051. Derived: 6-month figure less the 3-month figure.Capital expenditure: $111.0m. XBRL conceptus-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0002046386-26-000051. Derived: 6-month figure less the 3-month figure.Report this figure+594.3% on a year earlier
Last eight quarters
Full statements| Line item | Unit | period not labelled2025-03-29 | period not labelled2025-06-28 | Q1 FY20262026-03-28 | Q2 FY20262026-06-27 | Shape over the periods |
|---|---|---|---|---|---|---|
| Revenue | $m | 6,644Revenue, period not labelled, three months to 2025-03-29$6.64bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Report this figure | 6,886Revenue, period not labelled, three months to 2025-06-28$6.89bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Report this figure | 7,352Revenue, Q1 FY2026, three months to 2026-03-28$7.35bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Report this figure | 7,685Revenue, Q2 FY2026, three months to 2026-06-27$7.68bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Report this figure | |
| Gross margin | % | 27.5%Gross margin, period not labelled, three months to 2025-03-29. gross profit / revenueGross profit: $1.82bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Revenue: $6.64bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Report this figure | 27.7%Gross margin, period not labelled, three months to 2025-06-28. gross profit / revenueGross profit: $1.91bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Revenue: $6.89bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Report this figure | 25.0%Gross margin, Q1 FY2026, three months to 2026-03-28. gross profit / revenueGross profit: $1.84bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Revenue: $7.35bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Report this figure | 28.8%Gross margin, Q2 FY2026, three months to 2026-06-27. gross profit / revenueGross profit: $2.21bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Revenue: $7.68bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Report this figure | |
| Operating margin | % | 8.6%Operating margin, period not labelled, three months to 2025-03-29. operating income / revenueOperating income: $571.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Revenue: $6.64bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Report this figure | 9.3%Operating margin, period not labelled, three months to 2025-06-28. operating income / revenueOperating income: $642.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Revenue: $6.89bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Report this figure | 5.7%Operating margin, Q1 FY2026, three months to 2026-03-28. operating income / revenueOperating income: $422.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Revenue: $7.35bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Report this figure | 5.1%Operating margin, Q2 FY2026, three months to 2026-06-27. operating income / revenueOperating income: $395.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Revenue: $7.68bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Report this figure | |
| Net margin | % | 4.8%Net margin, period not labelled, three months to 2025-03-29. net income / revenueNet income: $319.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Revenue: $6.64bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Report this figure | 4.8%Net margin, period not labelled, three months to 2025-06-28. net income / revenueNet income: $329.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Revenue: $6.89bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Report this figure | 3.3%Net margin, Q1 FY2026, three months to 2026-03-28. net income / revenueNet income: $239.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Revenue: $7.35bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Report this figure | 1.8%Net margin, Q2 FY2026, three months to 2026-06-27. net income / revenueNet income: $139.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Revenue: $7.68bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Report this figure | |
| Diluted EPS | $ per share | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | 0.16Diluted EPS, Q1 FY2026, three months to 2026-03-28$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Report this figure | 0.07Diluted EPS, Q2 FY2026, three months to 2026-06-27$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0002046386-26-000051.Report this figure | |
| Free cash flow | $m | 584Free cash flow, period not labelled, three months to 2025-03-29. operating cash flow − capital expenditureOperating cash flow: $682.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Capital expenditure: $98.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Report this figure | 87.0Free cash flow, period not labelled, three months to 2025-06-28. operating cash flow − capital expenditureOperating cash flow: $197.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0002046386-26-000051. Derived: 6-month figure less the 3-month figure.Capital expenditure: $110.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0002046386-26-000051. Derived: 6-month figure less the 3-month figure.Report this figure | 316Free cash flow, Q1 FY2026, three months to 2026-03-28. operating cash flow − capital expenditureOperating cash flow: $412.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Capital expenditure: $96.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0002046386-26-000026.Report this figure | 604Free cash flow, Q2 FY2026, three months to 2026-06-27. operating cash flow − capital expenditureOperating cash flow: $715.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0002046386-26-000051. Derived: 6-month figure less the 3-month figure.Capital expenditure: $111.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0002046386-26-000051. Derived: 6-month figure less the 3-month figure.Report this figure |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Last five fiscal years
| Line item | Unit | FY2023-12-31 | FY2024-12-31 | FY20252025-12-31 | Shape over the periods |
|---|---|---|---|---|---|
| Revenue | $bn | 23.2Revenue, period not labelled, twelve months to 2023-12-31$23.23bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure | 25.5Revenue, period not labelled, twelve months to 2024-12-31$25.51bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure | 28.4Revenue, FY2025, twelve months to 2025-12-31$28.43bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure | |
| Gross margin | % | 25.3%Gross margin, period not labelled, twelve months to 2023-12-31. gross profit / revenueGross profit: $5.88bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0002046386-26-000009.Revenue: $23.23bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure | 27.3%Gross margin, period not labelled, twelve months to 2024-12-31. gross profit / revenueGross profit: $6.98bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0002046386-26-000009.Revenue: $25.51bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure | 26.4%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $7.52bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0002046386-26-000009.Revenue: $28.43bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure | |
| Operating margin | % | 5.4%Operating margin, period not labelled, twelve months to 2023-12-31. operating income / revenueOperating income: $1.25bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0002046386-26-000009.Revenue: $23.23bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure | 8.4%Operating margin, period not labelled, twelve months to 2024-12-31. operating income / revenueOperating income: $2.15bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0002046386-26-000009.Revenue: $25.51bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure | 7.8%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $2.21bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0002046386-26-000009.Revenue: $28.43bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure | |
| Net margin | % | 1.0%Net margin, period not labelled, twelve months to 2023-12-31. net income / revenueNet income: $234.0m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-02-25, accession 0002046386-26-000009.Revenue: $23.23bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure | 4.6%Net margin, period not labelled, twelve months to 2024-12-31. net income / revenueNet income: $1.16bn. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-02-25, accession 0002046386-26-000009.Revenue: $25.51bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure | 4.1%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $1.16bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0002046386-26-000009.Revenue: $28.43bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure | |
| Diluted EPS | $ per share | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | (0.01)Diluted EPS, FY2025, twelve months to 2025-12-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure | |
| Free cash flow | $bn | 1.4Free cash flow, period not labelled, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $1.69bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0002046386-26-000009.Capital expenditure: $275.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure | 1.4Free cash flow, period not labelled, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $1.77bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0002046386-26-000009.Capital expenditure: $354.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure | 1.3Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $1.74bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0002046386-26-000009.Capital expenditure: $447.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0002046386-26-000009.Report this figure |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Insider purchases and sales
All insider transactionsThe last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-28 | BCP 8 Holdings Mozart Manager L.L.C.10% owner | Sale | 1,489,924 | $36.5375 | $54.4m | Form 4 |
| 2026-05-28 | BCP 8 Holdings Mozart Manager L.L.C.10% owner | Sale | 2,256,800 | $36.5375 | $82.5m | Form 4 |
| 2026-05-28 | BCP 8 Holdings Mozart Manager L.L.C.10% owner | Sale | 9,858,774 | $36.5375 | $360.2m | Form 4 |
| 2026-05-28 | BCP 8 Holdings Mozart Manager L.L.C.10% owner | Sale | 19,712,326 | $36.5375 | $720.2m | Form 4 |
| 2026-03-10 | BCP 8 Holdings Mozart Manager L.L.C.10% owner | Sale | 1,245,544 | $40.508 | $50.5m | Form 4 |
| 2026-03-10 | BCP 8 Holdings Mozart Manager L.L.C.10% owner | Sale | 1,886,636 | $40.508 | $76.4m | Form 4 |
| 2026-03-10 | BCP 8 Holdings Mozart Manager L.L.C.10% owner | Sale | 8,241,723 | $40.508 | $333.9m | Form 4 |
| 2026-03-10 | BCP 8 Holdings Mozart Manager L.L.C.10% owner | Sale | 16,479,083 | $40.508 | $667.5m | Form 4 |
| 2025-12-18 | Mozart Aggregator II LP10% owner | Sale | 13,462,600 | $28.3683 | $381.9m | Form 4 |
Funds that report holding it
All fundsFrom each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|
| Carlyle Group Inc. | 2026-06-30 | $7.38bn | 187,083,713 | Unchanged | |
| H&F Corporate Investors X, Ltd. | 2026-06-30 | $2.80bn | 70,874,326 | Reduced−15,599,171 | |
| FMR LLC | 2026-06-30 | $1.85bn | 46,963,203 | Added+10,407,002 | |
| Capital Research Global Investors | 2026-06-30 | $1.58bn | 39,963,790 | Added+16,802,120 | |
| Invesco Ltd. | 2026-06-30 | $1.51bn | 38,346,937 | Added+17,383,322 | |
| BlackRock, Inc. | 2026-06-30 | $1.04bn | 26,393,587 | Added+9,469,927 | |
| MORGAN STANLEY | 2026-06-30 | $852.1m | 21,605,662 | Added+5,902,759 | |
| LONE PINE CAPITAL LLC | 2026-06-30 | $827.0m | 20,968,367 | Added+9,179,211 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2026-06-30 | $787.1m | 19,888,806 | Added+8,319,490 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2026-06-30 | $702.7m | 17,816,057 | Added+3,086,376 |
Recent filings
All 155 filingsReports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2120:17 ET | 8-K | 7.01 Regulation FD disclosure | 0001104659-26-117844 |
| 2026-10-1520:18 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-116255 |
| 2026-08-0520:48 ET | 10-Q | Quarterly reportPeriod 2026-06-27 | 0002046386-26-000051 |
| 2026-08-0511:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002046386-26-000049 |
| 2026-07-0920:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-082249 |
| 2026-06-1220:20 ET | 8-K | 5.07 Shareholder vote results | 0002046386-26-000037 |
| 2026-06-0212:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-252557 |
| 2026-05-2011:01 ET | S-1 | Registration statement | 0001193125-26-231691 |
| 2026-05-0620:18 ET | 10-Q | Quarterly reportPeriod 2026-03-28 | 0002046386-26-000026 |
| 2026-05-0611:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002046386-26-000022 |
Latest annual report
Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 25, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.
Forecast league
Q3 FY2026, the quarter ended 2026-09-27, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter
About the filer
- CIK
- 2046386
- Tickers
- MDLN
- Exchange
- Nasdaq
- SIC code
- 3841 Surgical & Medical Instruments & Apparatus
- Sector
- Healthcare
- Fiscal year ends
- Dec 31
- Incorporated in
- DE
- Filer category
- Non-accelerated filer
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.